Compugen Ltd Financial Statements (CGEN)
|
|
Report date
|
|
|
28.02.2022 |
31.12.2022 |
28.02.2023 |
23.08.2023 |
05.03.2024 |
|
30.09.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
6.00 |
7.50 |
7.50 |
7.50 |
33.5 |
|
59.9 |
Operating Income, bln rub |
|
|
-35.1 |
-35.4 |
-35.4 |
-35.4 |
-13.0 |
|
10.6 |
EBITDA, bln rub |
? |
|
-34.6 |
-35.4 |
-35.4 |
-35.4 |
-12.5 |
|
10.6 |
Net profit, bln rub |
? |
|
-32.9 |
-33.7 |
-33.7 |
-33.7 |
-18.8 |
|
1.60 |
|
OCF, bln rub |
? |
|
-22.8 |
-34.5 |
-34.5 |
-34.5 |
-35.9 |
|
|
CAPEX, bln rub |
? |
|
0.292 |
0.487 |
0.487 |
0.487 |
0.172 |
|
|
FCF, bln rub |
? |
|
-23.0 |
-35.0 |
-35.0 |
-35.0 |
-36.1 |
|
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
40.4 |
41.9 |
41.9 |
41.9 |
44.0 |
|
40.0 |
Cost of production, bln rub |
|
|
0.680 |
0.975 |
0.975 |
0.975 |
2.00 |
|
9.26 |
R&D, bln rub |
|
|
28.7 |
30.6 |
30.6 |
30.6 |
34.5 |
|
29.8 |
Interest expenses, bln rub |
|
|
0.025 |
0.027 |
0.027 |
0.027 |
0.031 |
|
0.000 |
|
Assets, bln rub |
|
|
132.2 |
94.2 |
94.2 |
94.2 |
121.3 |
|
123.5 |
Net Assets, bln rub |
? |
|
106.7 |
77.7 |
77.7 |
77.7 |
65.6 |
|
60.5 |
Debt, bln rub |
|
|
2.75 |
1.93 |
1.93 |
1.93 |
1.35 |
|
2.95 |
Cash, bln rub |
|
|
117.8 |
83.7 |
83.7 |
83.7 |
51.1 |
|
112.7 |
Net debt, bln rub |
|
|
-115.0 |
-81.8 |
-81.8 |
-81.8 |
-49.7 |
|
-109.8 |
|
Ordinary share price, rub |
|
|
4.30 |
0.716 |
0.716 |
0.716 |
1.98 |
|
0.760 |
Number of ordinary shares, mln |
|
|
84.2 |
86.6 |
86.6 |
86.6 |
87.6 |
|
89.5 |
|
Market cap, bln rub |
|
|
362 |
62 |
62 |
62 |
174 |
|
68 |
EV, bln rub |
? |
|
247 |
-20 |
-20 |
-20 |
124 |
|
-42 |
Book value, bln rub |
|
|
107 |
78 |
78 |
78 |
66 |
|
60 |
|
EPS, rub |
? |
|
-0.39 |
-0.39 |
-0.39 |
-0.39 |
-0.21 |
|
0.02 |
FCF/share, rub |
|
|
-0.27 |
-0.40 |
-0.40 |
-0.40 |
-0.41 |
|
0 |
BV/share, rub |
|
|
1.27 |
0.90 |
0.90 |
0.90 |
0.75 |
|
0.68 |
|
EBITDA margin, % |
? |
|
-576.9% |
-471.7% |
-471.7% |
-471.7% |
-37.4% |
|
17.7% |
Net margin, % |
? |
|
-547.9% |
-449.3% |
-449.3% |
-449.3% |
-56.1% |
|
2.67% |
FCF yield, % |
? |
|
-6.36% |
-56.5% |
-56.5% |
-56.5% |
-20.8% |
|
0.00% |
ROE, % |
? |
|
-30.8% |
-43.4% |
-43.4% |
-43.4% |
-28.6% |
|
2.64% |
ROA, % |
? |
|
-24.9% |
-35.8% |
-35.8% |
-35.8% |
-15.5% |
|
1.29% |
|
P/E |
? |
|
-11.0 |
-1.84 |
-1.84 |
-1.84 |
-9.25 |
|
42.6 |
P/FCF |
|
|
-15.7 |
-1.77 |
-1.77 |
-1.77 |
-4.81 |
|
|
P/S |
? |
|
60.3 |
8.26 |
8.26 |
8.26 |
5.19 |
|
1.14 |
P/BV |
? |
|
3.39 |
0.80 |
0.80 |
0.80 |
2.65 |
|
1.12 |
EV/EBITDA |
? |
|
-7.14 |
0.56 |
0.56 |
0.56 |
-9.89 |
|
-3.94 |
Debt/EBITDA |
|
|
3.32 |
2.31 |
2.31 |
2.31 |
3.97 |
|
-10.4 |
|
R&D/CAPEX, % |
|
|
9 827% |
6 293% |
6 293% |
6 293% |
20 042% |
|
|
|
CAPEX/Revenue, % |
|
|
4.87% |
6.49% |
6.49% |
6.49% |
0.51% |
|
0 |
|
Compugen Ltd shareholders |